These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 17207760

  • 1. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G, Schmid C, Loutan L, Chappuis F.
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud ME, Checchi F.
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [Abstract] [Full Text] [Related]

  • 3. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
    Buguet A, Bisser S, Josenando T, Chapotot F, Cespuglio R.
    Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
    [Abstract] [Full Text] [Related]

  • 4. An alternative form of melarsoprol in sleeping sickness.
    Kennedy PG.
    Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
    [Abstract] [Full Text] [Related]

  • 5. Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant.
    Mpandzou G, Cespuglio R, Ngampo S, Bandzouzi B, Bouteille B, Vincendeau P, Buguet A.
    J Neurol Sci; 2011 Jun 15; 305(1-2):112-5. PubMed ID: 21470639
    [Abstract] [Full Text] [Related]

  • 6. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P.
    J Infect Dis; 2007 Feb 01; 195(3):322-9. PubMed ID: 17205469
    [Abstract] [Full Text] [Related]

  • 7. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N, Maina KJ, Mäser P, Brun R.
    Acta Trop; 2007 Feb 01; 104(2-3):84-90. PubMed ID: 17765860
    [Abstract] [Full Text] [Related]

  • 8. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F, Udayraj N, Stietenroth K, Meussen A, Bovier PA.
    Clin Infect Dis; 2005 Sep 01; 41(5):748-51. PubMed ID: 16080099
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
    Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun R.
    Lancet; 2000 Apr 22; 355(9213):1419-25. PubMed ID: 10791526
    [Abstract] [Full Text] [Related]

  • 10. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ.
    Parasitol Res; 2003 May 22; 90(1):71-9. PubMed ID: 12743807
    [Abstract] [Full Text] [Related]

  • 11. Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan.
    Chappuis F, Stivanello E, Adams K, Kidane S, Pittet A, Bovier PA.
    Am J Trop Med Hyg; 2004 Sep 22; 71(3):313-7. PubMed ID: 15381812
    [Abstract] [Full Text] [Related]

  • 12. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
    Pépin J, Mpia B.
    Trans R Soc Trop Med Hyg; 2006 May 22; 100(5):437-41. PubMed ID: 16483622
    [Abstract] [Full Text] [Related]

  • 13. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
    Lejon V, Roger I, Mumba Ngoyi D, Menten J, Robays J, N'siesi FX, Bisser S, Boelaert M, Büscher P.
    Clin Infect Dis; 2008 Jul 01; 47(1):15-22. PubMed ID: 18494605
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
    Schmid C, Richer M, Bilenge CM, Josenando T, Chappuis F, Manthelot CR, Nangouma A, Doua F, Asumu PN, Simarro PP, Burri C.
    J Infect Dis; 2005 Jun 01; 191(11):1922-31. PubMed ID: 15871127
    [Abstract] [Full Text] [Related]

  • 15. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G, Kasparian S, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Karunakara U.
    Clin Infect Dis; 2007 Dec 01; 45(11):1435-42. PubMed ID: 17990225
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T, Yang S, Braissant O, Boykin DW, Brun R, Wang MZ.
    Antimicrob Agents Chemother; 2013 Nov 01; 57(11):5330-43. PubMed ID: 23959303
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
    Legros D, Fournier C, Gastellu Etchegorry M, Maiso F, Szumilin E.
    Bull Soc Pathol Exot; 1999 Jul 01; 92(3):171-2. PubMed ID: 10472443
    [Abstract] [Full Text] [Related]

  • 18. Suggested dosage rates of melarsoprol in the treatment of mice experimentally infected with Trypanosoma brucei gambiense.
    Mbati PA, Hirumi K, Inoue N, Situakibanza NH, Hirumi H.
    Onderstepoort J Vet Res; 2000 Mar 01; 67(1):71-4. PubMed ID: 10843325
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Human African trypanosomiasis].
    Dumas M, Bouteille B.
    C R Seances Soc Biol Fil; 1996 Mar 01; 190(4):395-408. PubMed ID: 8952890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.